{"id":"W4391303586","doi":"10.1200/jco.2024.42.4_suppl.tps719","title":"Pembrolizumab with favezelimab or vibostolimab for patients with bacillus Calmette-Guérin (BCG)–unresponsive high-risk (HR) non–muscle-invasive bladder cancer (NMIBC): Phase 2 KEYNOTE-057 cohort C.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Bladder cancer; Cohort; Bacillus (shape); Oncology; Internal medicine; Urology; Cancer; Immunotherapy; Microbiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000725484,0.0003870036,0.0006500584,0.0001989597,0.0003266605,0.0005187485,0.0003944344,0.0005337541,0.003203951],"category_scores_gemma":[0.0005599289,0.0002057318,0.0009130107,0.0002273696,0.0001750295,0.0004578897,0.0002599345,0.001013066,0.0005927244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008542642,"about_ca_system_score_gemma":0.001359484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001517753,"about_ca_topic_score_gemma":0.006560566,"domain_scores_codex":[0.9998524,0.00004388089,0.00001447137,0.00003054354,0.00001604765,0.00004267252],"domain_scores_gemma":[0.9997379,0.00002550821,0.00006617486,0.00001334975,0.00001878588,0.0001382861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4732199,0.01183806,0.1276454,0.002372406,0.003008671,0.0008133989,0.0003023716,0.001677115,0.0395813,0.0005411183,0.03014705,0.3088532],"study_design_scores_gemma":[0.2807004,0.2695447,0.383379,0.001053314,0.003465417,0.001849375,0.0003661436,0.002173157,0.00841529,0.0006507523,0.04833596,0.00006651966],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774956,0.008781946,0.0005310404,0.001357322,0.0001916206,0.00253818,0.003137637,0.00008641624,0.005880326],"genre_scores_gemma":[0.9882669,0.002421702,0.0008309332,0.00149924,0.0001332795,0.001167061,0.003910175,0.00001045872,0.001760363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003203951,"threshold_uncertainty_score":0.01071829,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.049694772448061,"score_gpt":0.426308802879533,"score_spread":0.376614030431472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}